HPLC purity vs mass spec identity: what each assay actually proves
If a certificate lists only one of these, it is incomplete in a way that matters. HPLC tells you how clean a sample is. Mass spectrometry tells you what it is. Neither substitutes for the other, and the distinction is not academic — it is the difference between a pure powder and the right pure powder.
HPLC: separation, then counting
Reverse-phase HPLC pushes the sample through a C18 column with a gradient of increasing acetonitrile. Molecules partition between the stationary phase and the mobile phase according to hydrophobicity, so they elute at different times. A detector at ~220 nm records the signal over time, and integrating the peaks gives area percentages — the number sold as purity.
The limitation is structural. HPLC quantifies what the detector sees, and the detector cannot see everything. A compound that co-elutes with the main peak is invisible to it, so a "99.5%" result can still be a mixture. What HPLC does exceptionally well is separating, quantifying and letting you see the trace — a clean single symmetric peak is meaningful evidence even when the exact percentage is method-dependent.
Mass spec: weighing the molecule
Electrospray ionisation transfers the peptide into the gas phase in charged droplets; as they evaporate, the molecules emerge protonated. The instrument then measures mass-to-charge ratio. The result is a fingerprint specific to the compound, and the definitive check is the observed molecular ion against the theoretical mass computed from the sequence.
For large peptides you will often see a doubly charged ion, where the molecule carries two protons and appears at roughly half its mass. That is not an error — it is often the most intense peak, because charge separation improves transmission.
- Adducts. Sodium or potassium replaces a proton, adding ~22 Da or ~38 Da. Expected, and subtractable.
- Deamidation. Glutamine or asparagine loses ammonia, about 17 Da. A real degradation pathway worth watching.
- Oxidation. Methionine gains 16 Da. Common in methionine-containing peptides, including growth-hormone secretagogues such as GHRP-2.
Why both are required
Consider two different failures. A sample of the right peptide contaminated with a peptide sequence error would pass a purity check — one clean peak, 99.8% — while being useless. Conversely, a sample of entirely the wrong compound, synthesised cleanly, would also pass purity at 99.8% while failing identity completely. Only the pair rules out both.
There is a third question neither answers: what the material will do in a system. That is why the third-party panel exists — endotoxin, residual solvents, heavy metals, sterility. Every lot we release is verified against all of them, using the methods in our third-party testing.
To see both numbers side by side, open the COA tab on any catalogue.
Composants cités
Chaque composé mentionné ci-dessus, avec son certificat d’analyse actuel.
Plus de notes de recherche
- Ipamorelin & CJC-1295 (DAC vs. No DAC): Pulsatile GH Release vs. Continuous Elevation in Preclinical Research
- BPC-157 and TB-500: The Molecular Synergy of Angiogenesis and Actin Upregulation
- Semaglutide vs. Tirzepatide: Comparing Mono-GLP-1 and Dual GLP-1/GIP Agonism in Laboratory Models
- Storage, reconstitution and cold chain: keeping peptides stable
- The five research categories, and what distinguishes them
- Choosing a fill size: 5 mg, 10 mg or 20 mg


